Narcotics Scanner Market |
Narcotics scanners are devices used for detecting illicit drugs and narcotics. They help in identifying drugs through technology like trace detection and Raman spectroscopy without having to touch or open packages. With the rising drug crimes globally, narcotics scanners help law enforcement agencies efficiently screen individuals, vehicles and premises for drugs.
The global
Narcotics Scanner Market is estimated to be valued at US$ 2735.68 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
Increased funding and support from various government organizations is one of
the key trends driving the growth of the narcotics scanner market. Governments
across major economies are spending heavily on advanced screening technologies
and devices to curb drug smuggling and abuse. For instance, in 2018, the US
government allocated a budget of over US$ 12 billion for law enforcement
agencies to procure full body scanners and narcotics trace detectors.
Similarly, European commission has implemented new directives mandating
installation of narcotics screening systems at major airports, borders and law
enforcement checkpoints. Such initiatives are helping vendors expand their
portfolio and geographical presence, thereby propelling the narcotics scanner
market growth over the forecast period.
Segment Analysis
The global narcotics scanner market is dominated by tabletop narcotics scanners
segment. Tabletop narcotics scanners are desktop devices that are easily
portable and can be operated without extensive training. They provide fast and
non-invasive screening of narcotics and are widely used by law and enforcement
agencies at airports, railway stations, and border checkpoints for scanning
luggage, parcels, and individuals in public places. Properties like compact
design, ease of use, and cost-effectiveness have made tabletop narcotics
scanners the most popular product type.
Key Takeaways
The global Narcotics
Scanner Market Share is expected
to witness high growth over the forecast period. The global Narcotics Scanner
Market is estimated to be valued at US$ 2735.68 Bn in 2023 and is expected to
exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.
North
America currently dominates the market owing to stringent regulations regarding
drug screening and high adoption of advanced screening technologies by law
enforcement agencies in countries like the US and Canada. The market is
expected to grow at the fastest rate in Asia Pacific due to rising drug
trafficking and government initiatives to curb smuggling of illegal substances
in countries like India and China. The presence of major players and adoption
of advanced technologies have contributed to the region's leading position.
Factors such as growing usage of narcotics, increasing trafficking of illegal
substances, and stringent government regulations regarding drug screening are
expected to drive the North American narcotics scanner market.
Key players
Key players operating in the narcotics scanner market include Akers
Biosciences, Inc., Philips Healthcare, Abbott Laboratories, GE Healthcare,
Nemaura Medical, Inc., Integrity Applications Inc., OrSense, MediWise Ltd., and
Medtronic Plc. Akers Biosciences, Inc. offers a portable desktop narcotics
scanner called TruNarc that provides rapid drug identification using Raman
spectroscopy. Philips Healthcare provides desktop and handheld narcotics
detection devices to identify illegal drugs and consumables.
For more
insights, read- https://www.ukwebwire.com/narcotics-scanner-market-market-size-and-share-analysis/
For more details on the report, Read- https://whotimes.com/change-harmony-exploring-the-dynamic-world-of-ion-exchange-membranes-for-applications/
0 Comments